High materiality8/10
Nautilus Biotechnology initiated with Buy at Roth Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Roth Capital initiates Nautilus Biotechnology with Buy; target $3.50; current price around $1.11.
- Target $3.50 vs price $1.11; Roth Capital Buy.
Key facts
- 01
Target: $3.5
- 02
Posted price: $1.11
- 03
Analyst firm: Roth Capital
- 04
Analyst: Max Masucci
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.